Aidspan, P, O, Box 66869-00800, Nairobi, Kenya.
Malar J. 2013 Dec 30;12:466. doi: 10.1186/1475-2875-12-466.
Although procurement consumes nearly 40% of Global Fund's money, no analyses have been published to show how costs vary across regions and time. This paper presents an analysis of malaria-related commodity procurement data from 79 countries, as reported through the Global Fund's price and quality reporting (PQR) system for the 2005-2012 period.
Data were analysed for the three most widely procured commodities for prevention, diagnosis and treatment of malaria. These were long-lasting insecticide-treated nets (LLINs), malaria rapid diagnostic tests (RDTs) and the artemether/lumefantrine (AL) combination treatment. Costs were compared across time (2005-2012), regions, and between individual procurement reported through the PQR and pooled procurement reported through the Global Fund's voluntary pooled procurement (VPP) system. All costs were adjusted for inflation and reported in US dollars.
The data included 1,514 entries reported from 79 countries over seven years. Of these, 492 entries were for LLINs, 330 for RDTs and 692 for AL. Considerable variations were seen by commodity, although none showed an increase in cost. The costs for LLINs, RDTs and AL all dropped significantly over the period of analysis. Regional variations were also seen, with the cost for all three commodities showing significant variations. The median cost for a single LLIN ranged from USD 4.3 in East Asia to USD 5.0 in West and Central Africa. The cost of a single RDT was lowest in West and Central Africa at US$ 0.57, and highest in the Latin American region at US$ 1.1. AL had the narrowest margin of between US$ 0.06 per tablet in sub-Saharan Africa and South Asia, and US$ 0.08 in the Latin American and Eastern Europe regions.
This paper concludes that global procurement costs do vary by region and have reduced overall over time. This suggests a mature market is operating when viewed from the global level, but regional variation needs further attention. Such analyses should be done more often to identify and correct market insufficiencies.
尽管采购消耗了全球基金近 40%的资金，但尚无分析报告显示各地区和各时期的成本差异。本文分析了全球基金价格和质量报告系统在 2005-2012 年期间报告的 79 个国家与疟疾相关的商品采购数据。
本文对预防、诊断和治疗疟疾的三种最广泛采购的商品进行了数据分析。这三种商品是长效驱虫蚊帐（LLINs）、疟疾快速诊断检测试剂（RDTs）和青蒿素/哌喹（AL）联合治疗。对 2005-2012 年期间的时间、地区以及个别通过 PQR 报告的采购和通过全球基金自愿集中采购（VPP）系统报告的集中采购进行了成本比较。所有成本均按通胀进行调整，并以美元报告。
数据包括来自 79 个国家的 7 年共 1514 项报告。其中，492 项是关于 LLINs 的，330 项是关于 RDTs 的，692 项是关于 AL 的。虽然没有一项成本增加，但不同商品之间存在相当大的差异。在分析期间，LLINs、RDTs 和 AL 的成本都显著下降。还观察到区域差异，所有三种商品的成本都有显著差异。单个 LLIN 的中位数成本范围从东亚的 4.3 美元到西非和中非的 5.0 美元。单个 RDT 的成本在西非和中非最低，为 0.57 美元，在拉丁美洲地区最高，为 1.1 美元。AL 的片剂价格差异最小，在撒哈拉以南非洲和南亚为 0.06 美元，在拉丁美洲和东欧地区为 0.08 美元。
本文认为，从全球层面看，采购成本因地区而异，且随时间推移总体呈下降趋势。这表明在全球范围内，一个成熟的市场正在运作，但区域差异仍需要进一步关注。应更频繁地进行此类分析，以发现和纠正市场不足。
